Clinical use of combined positron emission tomography and computed tomography in thymoma recurrence

Interactive Cardiovascular and Thoracic Surgery

Volumn 11, Issue 4, 2010, Pages 395-399

  El Bawab, Hatem Y ^a   Abouzied, Mohei M ^a   Rafay, Mohammed A ^a   Hajjar, Waseem M ^b   Saleh, Waleed M ^a   Alkattan, Khaled M ^a  

^a ALFAISAL UNIVERSITY   (Saudi Arabia)

^b KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Computed tomography; Myasthenia gravis; Positron emission tomography; Thymoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SURVEILLANCE; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STERNOTOMY; THORACOTOMY; THYMECTOMY; THYMOMA; TUMOR LOCALIZATION; TUMOR RECURRENCE; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ADOLESCENT; ADULT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THYMOMA; THYMUS NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 78249278475     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2010.236273     Document Type: Article

References (15)

1. Cohen DJ, Ronnigen LD, Graeber GM, Deshong JL, Jaffin J, Burge JR, Zajtchuk R. Management of patients with malignant thymoma. J Thorac Cardiovasc Surg 1984;87:301-307.
2. Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymoma: results of 241 operated cases. Ann Thorac Surg 1991;51:152-156.
3. El-Bawab H, Al-Sugair A, Rafay M, Hajjar W, Mahdy M, Al-Kattan K. Role of fluorine-18 fluorodeoxyglucose positron emission tomography in thymic pathology. Eur J Cardiothorac Surg 2007;31:731-736.
4. Endo M, Nakagawa K, Ohde Y, Okumura T, Kondo H, Igawa S, Nakamura Y, Tsuya A, Murakami H, Takahashi T, Yamamoto N, Ito I, Kameya T. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors. Lung Cancer 2008;61:350-355.
5. Liu RS, Yeh SH, Huang MH, Wang LS, Chu LS, Chang CP, Chu YK, Wu LC. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report. Eur J Nucl Med 1995;22:1402-1407.
6. Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 2002;225:575-581.
7. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, Jerin J, Young J, Byars L, Nutt R. A combined PETyCT scanner for clinical oncology. J Nucl Med 2000;41:1369-1379.
8. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
9. Attia J. Moving beyond sensitivity and specificity: using likelihood ratios to help interpret diagnostic tests. Australian Prescriber 2003;26:111-113.
10. Bury T, Corhay JL, Duysinx B, Daenen F, Ghaye B, Barthelemy N, Rigo P, Bartsch P. Value of FDG-PET in detecting residual or recurrent non-small cell lung cancer. Eur Respir J 1999;14:1376-1380.
11. Ito H, Shimada K, Isogami K, Kondo T, Kaneta T, Takahashi S, Fukuda H. Recurrence thymoma: radiological (CT and FDG-PET) and histological (WHO criteria) features. Radiat Med 2006;24:292-296.
12. Vesselle H, Schmidt RA, Pugsley JM, Li M, Kohlmyer SG, Vallires E, Wood DE. Lung cancer proliferation correlates with wF-18x fluorodeoxy-glucose uptake by positron emission tomography. Clin Cancer Res 2000;6:3837-3844.
13. Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T, Bockisch A, Debatin JF, Freudenberg LS. Accuracy of whole-body dual-modality fluorine-18 fluorodeoxy-D-glucose positron emission tomography and computed tomography (FDG-PETyCT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004;22:4357-4368.
14. Reinartz P, Wieres FJ, Schneider W, Schur A, Buell U. Side-by-side reading of PET and CT-scans in oncology: which patients might profit from integrated PETyCT? Eur J Nucl Med Mol Imaging 2004;31:1456-1461.
15. von Schulthess GK, Steinert HC, Hany TF. Integrated PETyCT: current applications and future directions. Radiology 2006;238:405-422.